Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 33

Trial Status

Other3

Role Distribution

Principal Investigator3
PI Rate100%

Activity Timeline

Clinical Trials (3)

NCT02603159Phase 3Unknown
Different Cycles of Capecitabine Usage in Esophageal Cancer Concurrent Chemoradiotherapy
Stage II Esophageal Squamous Cell CarcinomaStage III Esophageal Squamous Cell Carcinoma
Principalinvestigator
NCT02604615Phase 3Unknown
The Role of Different Cycles of Chemotherapy(Capecitabine-oxaliplatin) in Esophageal Chemoradiotherapy
Esophageal NeoplasmsStage III Esophageal Squamous Cell Carcinoma
Principalinvestigator
NCT02607540Phase 3Unknown
Different Cycles of Cisplatin-5-fluorouracil for the Chemoradiotherapy of Esophageal Squamous Cancer
Stage II Esophageal Squamous Cell CarcinomaStage III Esophageal Squamous Cell Carcinoma
Principalinvestigator

Research Network

Collaboration Network

18 collaborators·58 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

The First Affiliated Hospital of Henan University of Science and Technology

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Jing Ren, Master

The First Affiliated Hospital of Henan University of Science and Technology

Moderately Similar
3 trials

Shared therapeutic areas:

Stage III Esophageal Squamous Cell CarcinomaStage II Esophageal Squamous Cell CarcinomaEsophageal Neoplasms

Worked with same sponsors:

Anyang Tumor HospitalNo. 150 Central Hospital of the Chinese People Liberation Army+3 more
Collaborated on 3 trials
Similarity Score42%

Weijiao Yin, Master

The First Affiliated Hospital of Henan University of Science and Technology

Moderately Similar
3 trials

Shared therapeutic areas:

Stage III Esophageal Squamous Cell CarcinomaStage II Esophageal Squamous Cell CarcinomaEsophageal Neoplasms

Worked with same sponsors:

Anyang Tumor HospitalNo. 150 Central Hospital of the Chinese People Liberation Army+3 more
Collaborated on 3 trials
Similarity Score42%

Wei Wang, Master

The First Affiliated Hospital of Henan University of Science and Technology

Moderately Similar
3 trials

Shared therapeutic areas:

Stage III Esophageal Squamous Cell CarcinomaStage II Esophageal Squamous Cell CarcinomaEsophageal Neoplasms

Worked with same sponsors:

Anyang Tumor HospitalNo. 150 Central Hospital of the Chinese People Liberation Army+3 more
Collaborated on 3 trials
Similarity Score42%

Shegan Gao, Doctor

The First Affiliated Hospital of Henan University of Science and Technology

Moderately Similar
4 trials

Shared therapeutic areas:

Stage III Esophageal Squamous Cell CarcinomaStage II Esophageal Squamous Cell CarcinomaEsophageal Neoplasms

Worked with same sponsors:

Anyang Tumor HospitalNo. 150 Central Hospital of the Chinese People Liberation Army+3 more
Collaborated on 3 trials
Similarity Score42%

Guoqiang Kong, Master

The First Affiliated Hospital of Henan University of Science and Technology

Moderately Similar
3 trials

Shared therapeutic areas:

Stage III Esophageal Squamous Cell CarcinomaStage II Esophageal Squamous Cell CarcinomaEsophageal Neoplasms

Worked with same sponsors:

Anyang Tumor HospitalNo. 150 Central Hospital of the Chinese People Liberation Army+3 more
Collaborated on 3 trials
Similarity Score42%

Ruinuo Jia, Master

The First Affiliated Hospital of Henan University of Science and Technology

Moderately Similar
3 trials

Shared therapeutic areas:

Stage III Esophageal Squamous Cell CarcinomaStage II Esophageal Squamous Cell CarcinomaEsophageal Neoplasms

Worked with same sponsors:

Anyang Tumor HospitalNo. 150 Central Hospital of the Chinese People Liberation Army+3 more
Collaborated on 3 trials
Similarity Score42%

Ruina Yang, Master

The First Affiliated Hospital of Henan University of Science and Technology

Moderately Similar
3 trials

Shared therapeutic areas:

Stage III Esophageal Squamous Cell CarcinomaStage II Esophageal Squamous Cell CarcinomaEsophageal Neoplasms

Worked with same sponsors:

Anyang Tumor HospitalNo. 150 Central Hospital of the Chinese People Liberation Army+3 more
Collaborated on 3 trials
Similarity Score42%

Jiachun Sun, Doctor

The First Affiliated Hospital of Henan University of Science and Technology

Moderately Similar
3 trials

Shared therapeutic areas:

Stage III Esophageal Squamous Cell CarcinomaStage II Esophageal Squamous Cell CarcinomaEsophageal Neoplasms

Worked with same sponsors:

Anyang Tumor HospitalNo. 150 Central Hospital of the Chinese People Liberation Army+3 more
Collaborated on 3 trials
Similarity Score42%

Xiaozhi Yuan, Master

The First Affiliated Hospital of Henan University of Science and Technology

Moderately Similar
4 trials

Shared therapeutic areas:

Stage III Esophageal Squamous Cell CarcinomaStage II Esophageal Squamous Cell CarcinomaEsophageal Neoplasms

Worked with same sponsors:

Anyang Tumor HospitalNo. 150 Central Hospital of the Chinese People Liberation Army+3 more
Collaborated on 3 trials
Similarity Score42%

Xinshuai Wang, Doctor

The First Affiliated Hospital of Henan University of Science and Technology

Moderately Similar
3 trials

Shared therapeutic areas:

Stage III Esophageal Squamous Cell CarcinomaStage II Esophageal Squamous Cell CarcinomaEsophageal Neoplasms

Worked with same sponsors:

Anyang Tumor HospitalNo. 150 Central Hospital of the Chinese People Liberation Army+3 more
Collaborated on 3 trials
Similarity Score42%

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT02603159Phase 3PrincipalInvestigator

Different Cycles of Capecitabine Usage in Esophageal Cancer Concurrent Chemoradiotherapy

Stage II Esophageal Squamous Cell CarcinomaStage III Esophageal Squamous Cell Carcinoma
Unknown
NCT02604615Phase 3PrincipalInvestigator

The Role of Different Cycles of Chemotherapy(Capecitabine-oxaliplatin) in Esophageal Chemoradiotherapy

Esophageal NeoplasmsStage III Esophageal Squamous Cell Carcinoma
Unknown
NCT02607540Phase 3PrincipalInvestigator

Different Cycles of Cisplatin-5-fluorouracil for the Chemoradiotherapy of Esophageal Squamous Cancer

Stage II Esophageal Squamous Cell CarcinomaStage III Esophageal Squamous Cell Carcinoma
Unknown

All 3 trials loaded